AU5452194A - Enhancement of xenograft tolerance and porcine cytokines therefor - Google Patents
Enhancement of xenograft tolerance and porcine cytokines thereforInfo
- Publication number
- AU5452194A AU5452194A AU54521/94A AU5452194A AU5452194A AU 5452194 A AU5452194 A AU 5452194A AU 54521/94 A AU54521/94 A AU 54521/94A AU 5452194 A AU5452194 A AU 5452194A AU 5452194 A AU5452194 A AU 5452194A
- Authority
- AU
- Australia
- Prior art keywords
- porcine
- bone marrow
- marrow cells
- enhancement
- therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004127 Cytokines Human genes 0.000 title abstract 4
- 108090000695 Cytokines Proteins 0.000 title abstract 4
- 210000002798 bone marrow cell Anatomy 0.000 abstract 4
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
A method of enhancing tolerance of a porcine transplant in a xenogeneic recipient by administering porcine bone marrow cells to the recipient and of enhancing proliferation and engraftment of the porcine bone marrow cells by exposing said cells to at least one substantially pure porcine cytokine and porcine cytokines that are substantially free of other porcine proteins and preferentially enhance the proliferation and engraftment of porcine bone marrow cells in the presence of bone marrow cells of other species. Protein and DNA sequence(s) for such porcine cytokines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU50359/98A AU703371B2 (en) | 1992-10-27 | 1998-01-02 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96718892A | 1992-10-27 | 1992-10-27 | |
US967188 | 1992-10-27 | ||
US08/133,979 US5589582A (en) | 1992-10-27 | 1993-10-08 | Polynucleotides en coding porcine cytokines |
US133979 | 1993-10-08 | ||
PCT/US1993/010295 WO1994009803A1 (en) | 1992-10-27 | 1993-10-26 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50359/98A Division AU703371B2 (en) | 1992-10-27 | 1998-01-02 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5452194A true AU5452194A (en) | 1994-05-24 |
Family
ID=26831859
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54521/94A Abandoned AU5452194A (en) | 1992-10-27 | 1993-10-26 | Enhancement of xenograft tolerance and porcine cytokines therefor |
AU50359/98A Ceased AU703371B2 (en) | 1992-10-27 | 1998-01-02 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50359/98A Ceased AU703371B2 (en) | 1992-10-27 | 1998-01-02 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Country Status (8)
Country | Link |
---|---|
US (3) | US5589582A (en) |
EP (1) | EP0669829B1 (en) |
JP (1) | JP3784063B2 (en) |
AT (1) | ATE204019T1 (en) |
AU (2) | AU5452194A (en) |
CA (1) | CA2147989C (en) |
DE (1) | DE69330566T2 (en) |
WO (1) | WO1994009803A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
GB9515839D0 (en) * | 1995-08-02 | 1995-10-04 | Q One Biotech Ltd | Feline stem cell factor |
US6011197A (en) | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
US6447767B1 (en) | 1997-05-23 | 2002-09-10 | Hadasit Medical Research Services And Development Ltd. | Non-myeloablative tolerogenic treatment |
US6428782B1 (en) | 1997-05-23 | 2002-08-06 | Hadasit Medical Research Services And Development Ltd. | Non-myeloablative tolerogenic treatment |
WO1999009163A1 (en) * | 1997-08-13 | 1999-02-25 | Biotransplant, Inc. | Porcine stem cell factor varients and recombinant cells expressing such polypeptides |
AU8827998A (en) * | 1997-08-14 | 1999-03-08 | Biotransplant Incorporated | Porcine totipotent cells and method for long-term culture |
US6248587B1 (en) * | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
US6703209B1 (en) * | 1998-08-13 | 2004-03-09 | Biotransplant, Inc. | Porcine totipotent cells and method for long-term culture |
US6700037B2 (en) | 1998-11-24 | 2004-03-02 | Infigen, Inc. | Method of cloning porcine animals |
US6258998B1 (en) | 1998-11-24 | 2001-07-10 | Infigen, Inc. | Method of cloning porcine animals |
US6538028B1 (en) | 2000-02-01 | 2003-03-25 | Vanderbilt University | Method for inhibiting complement activation |
KR20040029311A (en) * | 2000-11-22 | 2004-04-06 | 제론 코포레이션 | Tolerizing allografts of pluripotent stem cells |
EP1379701A4 (en) * | 2001-03-28 | 2005-09-14 | Nextran Inc | Elimination of endogenous porcine retrovirus |
US20020152490A1 (en) * | 2001-04-12 | 2002-10-17 | Philip Lake | Tolerance-inducing thy-marrow composite tissue construct and organ |
WO2003039232A2 (en) * | 2001-10-26 | 2003-05-15 | Large Scale Biology Corporation | Endothelial cell derived hemotopoietic growth factor |
US7795493B2 (en) | 2002-08-21 | 2010-09-14 | Revivicor, Inc. | Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase |
AU2004290006A1 (en) | 2003-11-05 | 2005-05-26 | University Of Pittsburgh | Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
EP1734814B1 (en) | 2004-03-17 | 2015-01-21 | Revivicor, Inc. | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
US7489849B2 (en) * | 2004-11-03 | 2009-02-10 | Adc Telecommunications, Inc. | Fiber drop terminal |
PT2059256T (en) | 2006-08-11 | 2016-11-08 | Life Sciences Res Partners Vzw | Immunogenic peptides and their use in immune disorders |
WO2009101205A2 (en) * | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
ES2650236T3 (en) | 2008-02-14 | 2018-01-17 | Life Sciences Research Partners Vzw | CD4 + T lymphocytes with cytolytic properties |
AU2009214042B2 (en) | 2008-02-14 | 2014-02-13 | Katholieke Universiteit Leuven | Immunotherapy targeting intracellular pathogens |
ES2545885T3 (en) | 2008-02-14 | 2015-09-16 | Life Sciences Research Partners Vzw | Elimination of immune responses against viral vectors |
PL2249864T3 (en) * | 2008-02-14 | 2016-11-30 | Strategies to prevent and/or treat immune responses to soluble allofactors | |
US9248171B2 (en) * | 2008-02-14 | 2016-02-02 | Imcyse Sa | Immunogenic peptides and their use in transplantation |
US9420770B2 (en) | 2009-12-01 | 2016-08-23 | Indiana University Research & Technology Corporation | Methods of modulating thrombocytopenia and modified transgenic pigs |
HUE055070T2 (en) | 2010-11-25 | 2021-10-28 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
CN103547288B (en) * | 2011-01-10 | 2016-03-16 | 密执安大学评议会 | Stem cell factor inhibitor |
GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
US11787849B2 (en) | 2015-09-25 | 2023-10-17 | Imcyse Sa | Methods and compounds for eliminating immune responses to therapeutic agents |
WO2017182528A1 (en) | 2016-04-19 | 2017-10-26 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106733A (en) * | 1987-06-25 | 1992-04-21 | Immunex Corporation | Bovine granulocyte-macrophage colony stimulating factor |
DE69028514T2 (en) * | 1989-01-10 | 1997-02-20 | Amrad Corp Ltd | LEAKOMA-INHIBITING FACTOR FROM LIVESTOCK AND ITS USE FOR IMPLANTING AND IMPROVING EMBRYONAL CELLS |
DE69232438T2 (en) * | 1991-08-07 | 2002-10-10 | W French Anderson | INTERNAL RIBOSOM INPUTS INCLUDING RETROVIRAL VECTORS |
-
1993
- 1993-10-08 US US08/133,979 patent/US5589582A/en not_active Expired - Lifetime
- 1993-10-26 AT AT93925071T patent/ATE204019T1/en not_active IP Right Cessation
- 1993-10-26 DE DE69330566T patent/DE69330566T2/en not_active Expired - Fee Related
- 1993-10-26 JP JP51043494A patent/JP3784063B2/en not_active Expired - Fee Related
- 1993-10-26 AU AU54521/94A patent/AU5452194A/en not_active Abandoned
- 1993-10-26 EP EP93925071A patent/EP0669829B1/en not_active Expired - Lifetime
- 1993-10-26 WO PCT/US1993/010295 patent/WO1994009803A1/en active IP Right Grant
- 1993-10-26 CA CA002147989A patent/CA2147989C/en not_active Expired - Fee Related
-
1995
- 1995-05-08 US US08/436,890 patent/US5858963A/en not_active Expired - Lifetime
- 1995-05-26 US US08/451,213 patent/US5863528A/en not_active Expired - Lifetime
-
1998
- 1998-01-02 AU AU50359/98A patent/AU703371B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO1994009803A1 (en) | 1994-05-11 |
AU5035998A (en) | 1998-03-19 |
US5858963A (en) | 1999-01-12 |
EP0669829B1 (en) | 2001-08-08 |
EP0669829A1 (en) | 1995-09-06 |
ATE204019T1 (en) | 2001-08-15 |
EP0669829A4 (en) | 1997-05-07 |
DE69330566D1 (en) | 2001-09-13 |
US5863528A (en) | 1999-01-26 |
US5589582A (en) | 1996-12-31 |
DE69330566T2 (en) | 2002-06-27 |
CA2147989C (en) | 2002-10-22 |
CA2147989A1 (en) | 1994-05-11 |
AU703371B2 (en) | 1999-03-25 |
JPH08502650A (en) | 1996-03-26 |
JP3784063B2 (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5035998A (en) | Enhancement of xenograft tolerance and porcine cytokines therefor | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
CA2014965A1 (en) | Release of hematopoietic stem cells from affinity matrices | |
TW224055B (en) | ||
ATE275981T1 (en) | BONE TRANSPLANT COMPOSITES AND SPACERS | |
ES2007625A6 (en) | Novel osteoinductive compositions | |
ZA853690B (en) | Immunoregulation | |
HK206196A (en) | Acid-labile subunit (ALS) of insulin-like-growth factor (IGF) binding protein complex | |
HU9403006D0 (en) | Suppression of proliferative response and induction of tolerance wita polymorphil class ii.mal allopeptides | |
DE69627665D1 (en) | INDUCTION OF IMMUNOLOGICAL TOLERANCE USING NON-CELL REDUCING ANTI-CD4 ANTICOEPERS | |
DE3061854D1 (en) | Process for the preparation of interferon and culture medium composition used in it | |
DK12990A (en) | HUMAN GRANULOCYTE MACROPHAG COLONY STIMULATING FACTOR AND MUTEINES THEREOF | |
WO1993006852A3 (en) | Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein | |
AU6949994A (en) | Animal model for hepatitis virus infection | |
DE69527640T2 (en) | COMPOSITIONS CONTAINING MIXED TRANSFERRINE AS AN ACTIVE SUBSTANCE FOR INDUCTION OF IMMUNOTOLERANCE AGAINST ANTIGES | |
Hawley et al. | Porcine cytokines | |
DE69012105D1 (en) | Proliferation von cd4-lymfocyten. | |
AU1256495A (en) | Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor | |
DK0862453T3 (en) | Bone morphogenic protein and fibroblast growth factor preparations and methods for inducing cardiogenesis | |
FI951325A (en) | Transport of proteins by membrane transfer for pre-matching of xenogeneic transplants and other purposes | |
Hawley et al. | Polynucleotides en coding porcine cytokines | |
AU3330184A (en) | Immune interferon and method for its purification | |
IL105324A0 (en) | Stem cell proliferation factor | |
DK0528928T3 (en) | Interleukin-4 binding protein gamma | |
ATE263833T1 (en) | USE OF DENDRITIC CELL-DEPLETATED COMPOSITIONS TO IMPROVE ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION |